MINDGRAM
LIVE

Serial Number

90549353

Owner

Mindgram Technologies, LLC

Attorney

Gwenn Roos

First Use Date

Sep 1, 2020

Filing Date

Feb 26, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MINDGRAM Trademark

Serial Number: 90549353 • Registration: 6726313

MINDGRAM is a trademark filed by Mindgram Technologies, LLC on February 26, 2021. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Mindgram Technologies, LLC (2 trademarks)

Suite 700
Washington, DC 20005

Entity Type: 16

Trademark Details

Filing Date

February 26, 2021

Registration Date

May 24, 2022

First Use Anywhere

September 1, 2020

First Use in Commerce

September 1, 2020

Published for Opposition

November 2, 2021

Goods & Services

Computer programs, recorded, for for intellectual property research and analysis; Downloadable computer software for Downloadable and on-line computer programs for use in business, engineering, law, namely, law firms, pharmaceutical and biotechnology companies, and technology licensing departments, medicine, financial services, namely, venture capital, private equity and hedge funds, publishing, namely, research publications, trade organizations, research, and education; Downloadable computer programs for for tracking pharmaceutical and other drug development, including clinical trials; Downloadable computer software for for intellectual property research and analysis and instructional user guides sold as a unit; Downloadable computer operating programs; Downloadable computer software for for tracking pharmaceutical and other drug development, including clinical trials; Recorded computer programs for in text, image and data processing, mining, and analytics, and storage; Recorded computer software for in the integration, analysis and visualization of biomedically relevant information allowing program and software users to research and analyze data relating to drug compounds, drug targets, assays, biological pathways, mode of action, drug indication, and disease information, intellectual property, and human clinical trials, regulatory information, and market information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 6, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 5, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 8, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 8, 2022 AITU
USE AMENDMENT FILED
Feb 11, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 11, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2021 NWOS
NEW APPLICATION ENTERED
Mar 2, 2021 NWAP